[
    {
        "title": "T2 Biosystems stock sinks after rallying in prior session amid FDA ... - Seeking Alpha",
        "description": "T2 Biosystems stock sinks after rallying in prior session amid FDA ...  Seeking Alpha",
        "published date": "Tue, 19 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9uZXdzLzQwMTMyMDMtdDItYmlvc3lzdGVtcy1zdG9jay1zaW5rcy1hZnRlci1yYWxseWluZy1pbi1wcmlvci1zZXNzaW9uLWFtaWQtZmRhLW5ld3PSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "FDA grants priority review to belzutifan for advanced renal cell ... - Urology Times",
        "description": "FDA grants priority review to belzutifan for advanced renal cell ...  Urology Times",
        "published date": "Tue, 19 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LnVyb2xvZ3l0aW1lcy5jb20vdmlldy9mZGEtZ3JhbnRzLXByaW9yaXR5LXJldmlldy10by1iZWx6dXRpZmFuLWZvci1hZHZhbmNlZC1yZW5hbC1jZWxsLWNhcmNpbm9tYdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Trastuzumab Deruxtecan Revolutionizes Treatment in HER2+ ... - Targeted Oncology",
        "description": "Trastuzumab Deruxtecan Revolutionizes Treatment in HER2+ ...  Targeted Oncology",
        "published date": "Tue, 19 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L3RyYXN0dXp1bWFiLWRlcnV4dGVjYW4tcmV2b2x1dGlvbml6ZXMtdHJlYXRtZW50LWluLWhlcjItYnJlYXN0LWNhbmNlctIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]